September 20, 2016
(MIT Technology Review) – The problem is that the traditional system for clinical trials isn’t equal to the urgency patients like Gary face. To get into a clinical trial for gene therapy, patients must meet specific criteria set by drug makers. Among other things, the patients must fall into a certain age group and must have had symptoms for a defined period of time. Gary was fortunate enough to petition for the rules of one trial to be changed so he could enter. But many other people aren’t so lucky.
The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.